Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

On October 26, 2023, the Health Resources and Services Administration (HRSA) issued a Notice to “inform and remind” 340B Program covered entities that to be considered eligible for the 340B program, ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Despite the rancor, there are many bipartisan opportunities for the divided 118 th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug ...

Large hospital networks abuse the federal 340B drug discount program that was intended to boost small care providers. | ...